Alpha Spread
Search stocks here...
Sign Up Log in
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing Investing Ideas
Alpha Spread
Dashboard Tools Investing Ideas Pricing About Us
Sign Up
Log in
Alpha Spread
Dashboard Tools Investing Ideas Pricing About Us
Sign Up
Log in
Amryt Pharma Holdings Ltd Logo

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Dividends
Investor Relations
Discount Rate
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note
Write Note Create Alert Ask AI
Add Note Why Create Notes?
Capture your thoughts
Note Buy Sell Hold Pass
US
Johnson & Johnson
NYSE:JNJ
Pharmaceuticals
US
Berkshire Hathaway Inc
NYSE:BRK.A
Financial Services
US
Bank of America Corp
NYSE:BAC
Banking
US
Mastercard Inc
NYSE:MA
Technology
US
UnitedHealth Group Inc
NYSE:UNH
Health Care
US
Exxon Mobil Corp
NYSE:XOM
Energy
US
Pfizer Inc
NYSE:PFE
Pharmaceuticals
US
Palantir Technologies Inc
NYSE:PLTR
Technology
US
Nike Inc
NYSE:NKE
Textiles, Apparel & Luxury Goods
US
Visa Inc
NYSE:V
Technology
CN
Alibaba Group Holding Ltd
NYSE:BABA
Retail
US
JPMorgan Chase & Co
NYSE:JPM
Banking
US
Coca-Cola Co
NYSE:KO
Beverages
US
Walmart Inc
NYSE:WMT
Retail
US
Verizon Communications Inc
NYSE:VZ
Telecommunication
US
Chevron Corp
NYSE:CVX
Energy


Add Price Alert
Price Target:
Last Price: 143 GBX

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch
Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?
Close
Back
Delete Note

Do you really want to delete this note?
This action cannot be undone.

Delete
Cancel
AMYT Alert
Amryt Pharma Holdings Ltd
143
-19 (-11.73%)
52 Week Range
N/A
N/A
Price Target

We'll email you a reminder when the closing price reaches GBX.

Save Alert

Choose the stock you wish to monitor with a price alert.

Johnson & Johnson
NYSE:JNJ
US
Berkshire Hathaway Inc
NYSE:BRK.A
US
Bank of America Corp
NYSE:BAC
US
Mastercard Inc
NYSE:MA
US
UnitedHealth Group Inc
NYSE:UNH
US
Exxon Mobil Corp
NYSE:XOM
US
Pfizer Inc
NYSE:PFE
US
Palantir Technologies Inc
NYSE:PLTR
US
Nike Inc
NYSE:NKE
US
Visa Inc
NYSE:V
US
Alibaba Group Holding Ltd
NYSE:BABA
CN
JPMorgan Chase & Co
NYSE:JPM
US
Coca-Cola Co
NYSE:KO
US
Walmart Inc
NYSE:WMT
US
Verizon Communications Inc
NYSE:VZ
US
Chevron Corp
NYSE:CVX
US
Delete Alert

This alert will be permanently deleted.

Delete
Cancel
Ask me anything about
Amryt Pharma Holdings Ltd

What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?

What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?

Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.

Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.

Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.

What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?

What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?

Show all valuation multiples
for Amryt Pharma Holdings Ltd.

Provide P/S
for Amryt Pharma Holdings Ltd.

Provide P/E
for Amryt Pharma Holdings Ltd.

Provide P/OCF
for Amryt Pharma Holdings Ltd.

Provide P/FCFE
for Amryt Pharma Holdings Ltd.

Provide P/B
for Amryt Pharma Holdings Ltd.

Provide EV/S
for Amryt Pharma Holdings Ltd.

Provide EV/GP
for Amryt Pharma Holdings Ltd.

Provide EV/EBITDA
for Amryt Pharma Holdings Ltd.

Provide EV/EBIT
for Amryt Pharma Holdings Ltd.

Provide EV/OCF
for Amryt Pharma Holdings Ltd.

Provide EV/FCFF
for Amryt Pharma Holdings Ltd.

Provide EV/IC
for Amryt Pharma Holdings Ltd.

Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.

What are the Revenue projections
for Amryt Pharma Holdings Ltd?

How accurate were the past Revenue estimates
for Amryt Pharma Holdings Ltd?

What are the Net Income projections
for Amryt Pharma Holdings Ltd?

How accurate were the past Net Income estimates
for Amryt Pharma Holdings Ltd?

What are the EPS projections
for Amryt Pharma Holdings Ltd?

How accurate were the past EPS estimates
for Amryt Pharma Holdings Ltd?

What are the EBIT projections
for Amryt Pharma Holdings Ltd?

How accurate were the past EBIT estimates
for Amryt Pharma Holdings Ltd?

Compare the revenue forecasts
for Amryt Pharma Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amryt Pharma Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amryt Pharma Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amryt Pharma Holdings Ltd compared to its peers.

Compare the P/E ratios
of Amryt Pharma Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Amryt Pharma Holdings Ltd with its peers.

Analyze the financial leverage
of Amryt Pharma Holdings Ltd compared to its main competitors.

Show all profitability ratios
for Amryt Pharma Holdings Ltd.

Provide ROE
for Amryt Pharma Holdings Ltd.

Provide ROA
for Amryt Pharma Holdings Ltd.

Provide ROIC
for Amryt Pharma Holdings Ltd.

Provide ROCE
for Amryt Pharma Holdings Ltd.

Provide Gross Margin
for Amryt Pharma Holdings Ltd.

Provide Operating Margin
for Amryt Pharma Holdings Ltd.

Provide Net Margin
for Amryt Pharma Holdings Ltd.

Provide FCF Margin
for Amryt Pharma Holdings Ltd.

Show all solvency ratios
for Amryt Pharma Holdings Ltd.

Provide D/E Ratio
for Amryt Pharma Holdings Ltd.

Provide D/A Ratio
for Amryt Pharma Holdings Ltd.

Provide Interest Coverage Ratio
for Amryt Pharma Holdings Ltd.

Provide Altman Z-Score Ratio
for Amryt Pharma Holdings Ltd.

Provide Quick Ratio
for Amryt Pharma Holdings Ltd.

Provide Current Ratio
for Amryt Pharma Holdings Ltd.

Provide Cash Ratio
for Amryt Pharma Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for Amryt Pharma Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for Amryt Pharma Holdings Ltd?

What is the current Free Cash Flow
of Amryt Pharma Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amryt Pharma Holdings Ltd.

Popular Prompts Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Wall Street Price TargetsRevenue ForecastOperating Income ForecastNet Income ForecastSee Also
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+30%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

AMYT Price Targets Summary
Amryt Pharma Holdings Ltd

There are no price targets for AMYT.
AMYT Lowest Forecast
Wall Street Target
Not Available
AMYT Average Forecast
Wall Street Target
Not Available
AMYT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Amryt Pharma Holdings Ltd Competitors:
Price Targets
NEULANDLAB
Neuland Laboratories Ltd
29% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
14% Upside
W
016580
Whanin Pharm Co Ltd
37% Upside
ZTS
Zoetis Inc
27% Upside
NEULANDLAB
Neuland Laboratories Ltd
29% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
14% Upside
W
016580
Whanin Pharm Co Ltd
37% Upside
ZTS
Zoetis Inc
27% Upside
4502
Takeda Pharmaceutical Co Ltd
19% Upside
ATAI
ATAI Life Sciences NV
262% Upside
ORMP
Oramed Pharmaceuticals Inc
56% Upside
000423
Dong-E-E-Jiao Co Ltd
50% Upside

Revenue
Forecast

Revenue Estimate
Amryt Pharma Holdings Ltd

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

229%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amryt Pharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amryt Pharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AMYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMYT stock valuation using valuation multiples.
Wall Street Estimates
AMYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMYT's stock price target?
Not Available

AMYT doesn't have any price targets made by Wall Street professionals.

What is Amryt Pharma Holdings Ltd's Revenue forecast?
Projected CAGR
32%

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

What are analyst estimates?

Analyst estimates are projections made by market experts and financial analysts about a company's future performance.

These estimates are based on the analysts' research and understanding of the company's business model, industry trends, economic conditions, and other relevant factors.

Close
Alpha Spread
Become a more intelligent investor
Sign up with Google
OR
Sign up with email
Already have an account? Sign in
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Sign In
Become a more intelligent investor
Sign in with Google
OR
Sign in with email
Not a member? Sign Up
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Recently Viewed Most Popular Most Undervalued Wide Economic Moat High Profitability High Solvency
Amryt Pharma Holdings Ltd
LSE:AMYT
143 GBX
-11.73%

Companies most frequently analyzed and tracked by Alpha Spread users.

Johnson & Johnson
NYSE:JNJ
150.665 USD
0.58%
Berkshire Hathaway Inc
NYSE:BRK.A
728 574.99 USD
-0.2%
Bank of America Corp
NYSE:BAC
45.92 USD
0.92%
Mastercard Inc
NYSE:MA
538.0268 USD
0.95%
UnitedHealth Group Inc
NYSE:UNH
301.29 USD
-0.24%
Exxon Mobil Corp
NYSE:XOM
111.68 USD
-2.63%
View Most Popular Stocks Full List

Every business has a fair value, its true price. Where market price tells you the price other people are willing to pay, fair value shows the value of a stock based on an analysis of the company’s actual financials (such as cash balance, revenue, operating margin, etc).

Franklin Covey Co
NYSE:FC
22.6118 USD
1.53%
Mohawk Industries Inc
NYSE:MHK
102.095 USD
2.58%
Ardmore Shipping Corp
NYSE:ASC
9.94 USD
-1.88%
ASGN Inc
NYSE:ASGN
48.73 USD
0.31%
Skyworks Solutions Inc
NASDAQ:SWKS
72.31 USD
0.25%
Weatherford International PLC
NASDAQ:WFRD
47.46 USD
-7.01%
View Most Undervalued Stocks Full List

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term.

Johnson & Johnson
NYSE:JNJ
150.665 USD
0.58%
Bank of America Corp
NYSE:BAC
45.92 USD
0.92%
Mastercard Inc
NYSE:MA
538.0268 USD
0.95%
Salesforce Inc
NYSE:CRM
262.8 USD
0.83%
Abbvie Inc
NYSE:ABBV
183.965 USD
-0.72%
Home Depot Inc
NYSE:HD
354.44 USD
1.38%
View Wide Economic Moat Stocks Full List

Companies demonstrating exceptional profitability and efficient operations.

Arista Networks Inc
NYSE:ANET
92.02 USD
6.69%
Deckers Outdoor Corp
NYSE:DECK
99.65 USD
-2.01%
Visa Inc
NYSE:V
342.29 USD
1.1%
Texas Pacific Land Corp
NYSE:TPL
1 055.3199 USD
-2.66%
KLA Corp
NASDAQ:KLAC
855.085 USD
0.6%
Manhattan Associates Inc
NASDAQ:MANH
192 USD
3.07%
View High Profitability Stocks Full List

Companies with the lowest probability of bankruptcy.

Salesforce Inc
NYSE:CRM
262.8 USD
0.83%
Accenture PLC
NYSE:ACN
292.79 USD
2.6%
ServiceNow Inc
NYSE:NOW
978.85 USD
0.77%
Spotify Technology SA
NYSE:SPOT
728.265 USD
2.95%
EOG Resources Inc
NYSE:EOG
122.56 USD
-2.2%
Monster Beverage Corp
NASDAQ:MNST
63.02 USD
-0.11%
View High Solvency Stocks Full List
Stock Screener
Discover stocks tailored to your investment strategy.
Open Stock Screener
You don't have any saved screeners yet
Other Tools
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF
Discount Rate Calculator
Cost of Equity & WACC

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett
Warning
AMYT is delisted

This means that the stock is removed from a stock exchange and can no longer be traded.

Delisting typically occurs when a stock no longer meets exchange requirements. Other reasons for delisting may include legal violations, bankruptcy, a decrease in the number of shareholders, and acquisition by another company.

Close
Create Your Free Account
Already have an account? Sign in
Gain access to the world’s leading value investing platform
Gain access to the world’s leading value investing platform

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.

Sign up with Google
OR
Create Free Account

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.